Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;19(6):e2300662.
doi: 10.1002/biot.202300662.

Clioquinol rescues yeast cells from Aβ42 toxicity via the inhibition of oxidative damage

Qiaoqiao Zheng  1 , Hongzheng Zhu  1 , Chunyi Lv  1 , Ziting Zhu  1 , Hanyue Cui  1 , Zheyu Fan  1 , Jing Sun  2 , Zhiwei Huang  3 , Ping Shi  1
Affiliations

Clioquinol rescues yeast cells from Aβ42 toxicity via the inhibition of oxidative damage

Qiaoqiao Zheng et al. Biotechnol J. 2024 Jun.

Abstract

Alzheimer's disease (AD), the most common form of dementia, has gotten considerable attention. Previous studies have demonstrated that clioquinol (CQ) as a metal chelator is a potential drug for the treatment of AD. However, the mode of action of CQ in AD is still unclear. In our study, the antioxidant effects of CQ on yeast cells expressing Aβ42 were investigated. We found that CQ could reduce Aβ42 toxicity by alleviating reactive oxygen species (ROS) generation and lipid peroxidation level in yeast cells. These alterations were mainly attributable to the increased reduced glutathione (GSH) content and independent of activities of superoxide dismutase (SOD) and/or catalase (CAT). CQ could affect antioxidant enzyme activity by altering the transcription level of related genes. Interestingly, it was noted for the first time that CQ could combine with antioxidant enzymes to reduce their enzymatic activities by molecular docking and circular dichroism spectroscopy. In addition, CQ restored Aβ42-mediated disruption of GSH homeostasis via regulating YAP1 expression to protect cells against oxidative stress. Our findings not only improve the current understanding of the mechanism of CQ as a potential drug for AD treatment but also provide ideas for subsequent drug research and development.

Keywords: Alzheimer's disease; amyloid beta; clioquinol; oxidative stress; yeast.

PubMed Disclaimer

Similar articles

See all similar articles

References

REFERENCES

    1. Koychev, I., Hofer, M., & Friedman, N. (2020). Correlation of Alzheimer disease neuropathologic staging with amyloid and tau scintigraphic imaging biomarkers. Journal of Nuclear Medicine, 61(10), 1413–1418. https://doi.org/10.2967/jnumed.119.230458
    1. Zoltowska, K. M., & Berezovska, O. (2018). Dynamic nature of presenilin1/γ‐secretase: Implication for Alzheimer's disease pathogenesis. Molecular Neurobiology, 55(3), 2275–2284. https://doi.org/10.1007/s12035‐017‐0487‐5
    1. Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020). Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease. Molecular Neurodegeneration, 15(1), 40. https://doi.org/10.1186/s13024‐020‐00391‐7
    1. Du, X., Wang, X., & Geng, M. (2018). Alzheimer's disease hypothesis and related therapies. Translational Neurodegeneration, 7, 2. https://doi.org/10.1186/s40035‐018‐0107‐y
    1. Silva, M. V. F., Loures, C. M. G., Alves, L. C. V., de Souza, L. C., Borges, K. B. G., & Carvalho, M. D. G. (2019). Alzheimer's disease: Risk factors and potentially protective measures. Journal of Biomedical Science, 26(1), 33. https://doi.org/10.1186/s12929‐019‐0524‐y

MeSH terms

LinkOut - more resources

-